Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Xu P, Zhu Y, Shi ZY, Wang L, et al. A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma. Blood 2025 Aug 19:blood.2025028649. doi: 10.1182/blood.2025028649.
PMID: 40829156


Privacy Policy